Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The Pro Medicus Ltd (ASX:PME) share price is up another 3.5% today after another contract win.
Tony Hansen from EGP Capital takes in depth look at the future of Redbubble Ltd (ASX: RBL), given his past experiences with near $10 billion plumbing business Reece Group Ltd (ASX: REH).
Pro Medicus Ltd (ASX:PME) has announced another contract win in Europe, with a large German university hospital.
Pro Medicus Ltd (ASX:PME) has announced today that it continues to win market share in the US after winning a contract with NYU Langone Health.
In the second installment of our ASX Reporting Season Results Recap, myself and Wattle Partners financial adviser Drew Meredith, look at the reports from EML Payments Ltd (ASX:EML), Kogan.com Ltd (ASX:KGN), Pro Medicus Ltd (ASX:PME) and JB Hi-Fi Limited (ASX:JBH).
The Pro Medicus Ltd (ASX:PME) share price is down more than 5% in reaction to the company’s FY20 result.
Pro Medicus (ASX:PME) has won another sizeable contract in the US. Is it time to buy shares?
Melbourne-based Pro Medicus Ltd (ASX:PME) shares were trading 5% higher on Thursday following the release of its financial report.
The Pro Medicus (ASX:PME) share price is up after announcing a new US deal with Nines.
